Cite
HARVARD Citation
Xu, X. et al. (2017). Response to "The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma". Clinical pharmacology & therapeutics. 102 (6), p. 905. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, X. et al. (2017). Response to "The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma". Clinical pharmacology & therapeutics. 102 (6), p. 905. [Online].